Humacyte Inc
HUMA
Market Cap$650.23M
Close$
$0.24
90.8% downside
Current Fair Value
90.8% downsideOvervalued by 90.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $650.23 Million |
|---|---|
| Enterprise Value | $608.80 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.07 |
| Beta | 1.45 |
| Outstanding Shares | 119,174,681 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.64 |
|---|---|
| PEG | 2.08 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 78.61 |
| Enterprise Value to EBIT | -6.01 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.59 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Alpha Healthcare Acquisition Corp.
CEO: Mr. Rajiv Sarman Shukla Alpha Healthcare Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in New York, New York.